NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

What the buyer is asking for

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.

How this is scored

Published by the buyer. A winning response is written to these weightings, not to the question.

• 30%qualityTechnical QualityBidder specification (Technical Quality) 30% and Pass / Fail Mandatory requirementselements)
• 10%qualitySocial Value SustainabilityBidder Specification (Social Value and sustainability) - 10% weighted scoring
• 60%priceCommercialCommercial Evaluation (Price) - 60% weighted scoring

How contested is this?

Buyers publish how many bids they received. Across 61 comparable procurements we can tell you the typical field size, how often one of these goes uncontested, and whether the buyer awards on price or on quality.

Timeline

4 published dates · Europe/London

1. Tender notice published24 days ago

   13 Oct 2026, 11:51 BST
2. Clarification questions bytoday

   6 Nov 2026, 12:00 GMT
3. Submission deadlinein 24 days

   30 Nov 2026, 12:00 GMT
4. Award decision expected byin 144 days

   30 Mar 2027, 23:59 BST

Commercial outcome and contract awards

Nothing awarded yet

Notice history

3 events · 3 releases on Find a Tender

1. Pipeline or early engagement notice23 Sept 2026, 12:42 BST090106-2026
2. Pipeline or early engagement notice23 Sept 2026, 12:50 BST090112-2026
3. Tender notice13 Oct 2026, 11:51 BST096479-2026

Documents

• Invitation to Tender for Unlicensed Imported Medicines
• Tender notice on Find a Tender